82 related articles for article (PubMed ID: 18566537)
1. Fibroblast growth factor receptor and platelet-derived growth factor receptor abnormalities in eosinophilic myeloproliferative disorders.
Cross NC; Reiter A
Acta Haematol; 2008; 119(4):199-206. PubMed ID: 18566537
[TBL] [Abstract][Full Text] [Related]
2. Transforming fusions of FGFR and TACC genes in human glioblastoma.
Singh D; Chan JM; Zoppoli P; Niola F; Sullivan R; Castano A; Liu EM; Reichel J; Porrati P; Pellegatta S; Qiu K; Gao Z; Ceccarelli M; Riccardi R; Brat DJ; Guha A; Aldape K; Golfinos JG; Zagzag D; Mikkelsen T; Finocchiaro G; Lasorella A; Rabadan R; Iavarone A
Science; 2012 Sep; 337(6099):1231-5. PubMed ID: 22837387
[TBL] [Abstract][Full Text] [Related]
3. Fusion of Platelet Derived Growth Factor Receptor Alpha (
Panagopoulos I; Andersen K; Gorunova L; Lobmaier I
Cancer Genomics Proteomics; 2024; 21(3):252-259. PubMed ID: 38670591
[TBL] [Abstract][Full Text] [Related]
4. [Bone destruction was the initial symptom in myeloid/lymphoid neoplasms associated with eosinophilia and rearrangements of PDGFRα: a case report].
Guo Y; Lyu GQ; Zhang Y; Wang LH; Wu JR; Lu XL; Qin WL; Wu S
Zhonghua Xue Ye Xue Za Zhi; 2024 Feb; 45(2):195. PubMed ID: 38604798
[No Abstract] [Full Text] [Related]
5. RNA-Binding Proteins in Acute Leukemias.
Schuschel K; Helwig M; Hüttelmaier S; Heckl D; Klusmann JH; Hoell JI
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32408494
[TBL] [Abstract][Full Text] [Related]
6. [Eosinophilic granulocytes-Physiology and pathophysiology].
Sokollik C; Simon HU
Z Rheumatol; 2019 May; 78(4):306-312. PubMed ID: 30627844
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic application of next-generation sequencing in ZMYM2-FGFR1 8p11 myeloproliferative syndrome: A case report.
Wang Y; Wu X; Deng J; Yu H; Xu R; Zhu Z; Tu S; Hu Y
Cancer Biol Ther; 2016 Aug; 17(8):785-9. PubMed ID: 27415155
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor (FGF) signaling in development and skeletal diseases.
Teven CM; Farina EM; Rivas J; Reid RR
Genes Dis; 2014 Dec; 1(2):199-213. PubMed ID: 25679016
[TBL] [Abstract][Full Text] [Related]
9. Novel targeted therapies for eosinophil-associated diseases and allergy.
Radonjic-Hoesli S; Valent P; Klion AD; Wechsler ME; Simon HU
Annu Rev Pharmacol Toxicol; 2015; 55():633-56. PubMed ID: 25340931
[TBL] [Abstract][Full Text] [Related]
10. The serum tryptase test: an emerging robust biomarker in clinical hematology.
Valent P; Sperr WR; Sotlar K; Reiter A; Akin C; Gotlib J; Horny HP; Arock M
Expert Rev Hematol; 2014 Oct; 7(5):683-90. PubMed ID: 25169217
[TBL] [Abstract][Full Text] [Related]
11. Changing histopathological diagnostics by genome-based tumor classification.
Kloth M; Buettner R
Genes (Basel); 2014 May; 5(2):444-59. PubMed ID: 24879454
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory myofibroblastic tumors harbor multiple potentially actionable kinase fusions.
Lovly CM; Gupta A; Lipson D; Otto G; Brennan T; Chung CT; Borinstein SC; Ross JS; Stephens PJ; Miller VA; Coffin CM
Cancer Discov; 2014 Aug; 4(8):889-95. PubMed ID: 24875859
[TBL] [Abstract][Full Text] [Related]
13. Centrosome-kinase fusions promote oncogenic signaling and disrupt centrosome function in myeloproliferative neoplasms.
Lee JY; Hong WJ; Majeti R; Stearns T
PLoS One; 2014; 9(3):e92641. PubMed ID: 24658090
[TBL] [Abstract][Full Text] [Related]
14. Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma.
Borad MJ; Champion MD; Egan JB; Liang WS; Fonseca R; Bryce AH; McCullough AE; Barrett MT; Hunt K; Patel MD; Young SW; Collins JM; Silva AC; Condjella RM; Block M; McWilliams RR; Lazaridis KN; Klee EW; Bible KC; Harris P; Oliver GR; Bhavsar JD; Nair AA; Middha S; Asmann Y; Kocher JP; Schahl K; Kipp BR; Barr Fritcher EG; Baker A; Aldrich J; Kurdoglu A; Izatt T; Christoforides A; Cherni I; Nasser S; Reiman R; Phillips L; McDonald J; Adkins J; Mastrian SD; Placek P; Watanabe AT; Lobello J; Han H; Von Hoff D; Craig DW; Stewart AK; Carpten JD
PLoS Genet; 2014 Feb; 10(2):e1004135. PubMed ID: 24550739
[TBL] [Abstract][Full Text] [Related]
15. Effect of the tyrosine kinase inhibitor nilotinib in patients with hypereosinophilic syndrome/chronic eosinophilic leukemia: analysis of the phase 2, open-label, single-arm A2101 study.
Hochhaus A; le Coutre PD; Kantarjian HM; Baccarani M; Erben P; Reiter A; McCulloch T; Fan X; Novick S; Giles FJ
J Cancer Res Clin Oncol; 2013 Dec; 139(12):1985-93. PubMed ID: 24057647
[TBL] [Abstract][Full Text] [Related]
16. Review of current classification, molecular alterations, and tyrosine kinase inhibitor therapies in myeloproliferative disorders with hypereosinophilia.
Havelange V; Demoulin JB
J Blood Med; 2013; 4():111-21. PubMed ID: 23976869
[TBL] [Abstract][Full Text] [Related]
17. Inherited predisposition to myeloproliferative neoplasms.
Jones AV; Cross NC
Ther Adv Hematol; 2013 Aug; 4(4):237-53. PubMed ID: 23926457
[TBL] [Abstract][Full Text] [Related]
18. KIT signaling governs differential sensitivity of mature and primitive CML progenitors to tyrosine kinase inhibitors.
Corbin AS; O'Hare T; Gu Z; Kraft IL; Eiring AM; Khorashad JS; Pomicter AD; Zhang TY; Eide CA; Manley PW; Cortes JE; Druker BJ; Deininger MW
Cancer Res; 2013 Sep; 73(18):5775-86. PubMed ID: 23887971
[TBL] [Abstract][Full Text] [Related]
19. ICON: Eosinophil Disorders.
Valent P; Klion AD; Rosenwasser LJ; Arock M; Bochner BS; Butterfield JH; Gotlib J; Haferlach T; Hellmann A; Horny HP; Leiferman KM; Metzgeroth G; Matsumoto K; Reiter A; Roufosse F; Rothenberg ME; Simon HU; Sotlar K; Vandenberghe P; Weller PF; Gleich GJ
World Allergy Organ J; 2012 Dec; 5(12):174-81. PubMed ID: 23282419
[No Abstract] [Full Text] [Related]
20. Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia.
Roberts KG; Morin RD; Zhang J; Hirst M; Zhao Y; Su X; Chen SC; Payne-Turner D; Churchman ML; Harvey RC; Chen X; Kasap C; Yan C; Becksfort J; Finney RP; Teachey DT; Maude SL; Tse K; Moore R; Jones S; Mungall K; Birol I; Edmonson MN; Hu Y; Buetow KE; Chen IM; Carroll WL; Wei L; Ma J; Kleppe M; Levine RL; Garcia-Manero G; Larsen E; Shah NP; Devidas M; Reaman G; Smith M; Paugh SW; Evans WE; Grupp SA; Jeha S; Pui CH; Gerhard DS; Downing JR; Willman CL; Loh M; Hunger SP; Marra MA; Mullighan CG
Cancer Cell; 2012 Aug; 22(2):153-66. PubMed ID: 22897847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
